Rigel Pharmaceuticals Inc... (RIGL)
22.34
-0.72 (-3.12%)
At close: Mar 03, 2025, 3:59 PM
23.01
3.00%
Pre-market: Mar 04, 2025, 04:07 AM EST
Rigel Pharmaceuticals Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 |
| Net Income | -25.09M | -58.57M | -17.91M | -29.74M | -66.89M | -70.48M | -77.99M | -69.22M | -51.46M | -90.91M | -89.03M | -98.84M | -85.97M | 37.89M | -111.55M | -132.35M | -74.27M | -37.64M | -45.26M | -56.26M | -41.2M | -37.03M | -23.8M | -25.36M | -12.37M |
| Depreciation & Amortization | 1.24M | 998K | 1.16M | 706K | 683K | 594K | 465K | 941K | 1.44M | 2.36M | 2.59M | 2.43M | 1.96M | 1.32M | 1.4M | 1.43M | 1.34M | 1.42M | 1.18M | 2.37M | 3.18M | 5.82M | 6.76M | 7.56M | 1.91M |
| Stock-Based Compensation | 8.81M | 12.38M | 9.49M | 7.3M | 9.12M | 7.7M | 5.99M | 7.33M | 7.4M | 9.79M | 7.17M | 12.62M | 13.17M | 16.44M | 13.44M | n/a | 11.69M | 12.58M | 30K | 127K | 513K | 956K | 2.63M | 4.88M | n/a |
| Other Working Capital | -1.06M | -5.61M | 14.05M | -24M | 25.3M | 5.28M | -2.48M | -20.89M | 11.77M | 2.1M | -4.61M | -1.54M | 1.32M | -7.15M | -3.24M | 3.64M | 3.81M | -12.95M | 118.95M | 62.82M | 42.06M | 22.49M | 26.37M | 46.63M | 931K |
| Other Non-Cash Items | -213K | 481K | 3.14M | -122K | -1.07M | -766K | 495K | 818K | -57K | 9.3M | 2.19M | 11.2M | -85.97M | n/a | n/a | 23.76M | 11.69M | 12.58M | -2.12M | 2.47M | 917K | -176K | -510K | 5.28M | 1.7M |
| Deferred Income Tax | n/a | n/a | 287K | n/a | n/a | n/a | -1.08M | 27K | n/a | -98K | n/a | n/a | 85.97M | n/a | n/a | n/a | -11.69M | -12.58M | -30K | -127K | -513K | -956K | -2.63M | -2.73M | n/a |
| Change in Working Capital | 9.52M | -29.05M | 9.72M | -30.32M | 16.66M | 4.12M | -5.43M | -15.79M | 19.27M | -195K | -6.79M | -1.4M | 1.48M | -8.9M | -6.07M | 3.64M | 9.03M | -12.2M | 11.03M | 13.26M | 4.66M | -3.15M | 1.57M | -1.22M | 931K |
| Operating Cash Flow | -5.74M | -73.76M | 5.88M | -52.19M | -41.51M | -58.83M | -77.56M | -75.89M | -23.41M | -69.75M | -86.06M | -85.19M | -69.38M | 46.74M | -102.78M | -103.52M | -52.21M | -35.84M | -35.17M | -38.15M | -32.44M | -34.53M | -15.98M | -11.59M | -7.83M |
| Capital Expenditures | -15M | -450K | -627K | -1.26M | -1.46M | -1.11M | -164K | -804K | -546K | -413K | -1.22M | -3.38M | -2.3M | -3.56M | -141K | -2.51M | -933K | -913K | -1.79M | -1.54M | -1.24M | -1.64M | -3.23M | -3.62M | -7.09M |
| Acquisitions | n/a | 893K | 627K | 1.26M | 1.46M | 1.11M | 732K | 88K | 60K | n/a | 1.22M | 3.38M | 2.3M | 3.56M | 141K | n/a | n/a | n/a | n/a | n/a | n/a | -24.96M | n/a | n/a | n/a |
| Purchase of Investments | -31.21M | -28.89M | -141.46M | -81.71M | -145.33M | -78M | -116.86M | -103.05M | -151.76M | -218.59M | -308.85M | -475.4M | -476.04M | -266.09M | -169.93M | -194.6M | -134.37M | -85.21M | -89.58M | -96.44M | -42.13M | -26.71M | -47.51M | -3.96M | n/a |
| Sales Maturities Of Investments | 41.65M | 101.23M | 62.05M | 130.43M | 123.13M | 104.07M | 96.82M | 128.65M | 196.86M | 281.7M | 382.45M | 439.72M | 415.49M | 216.25M | 139.39M | 170.12M | 127.51M | 89.99M | 89.23M | 72.18M | 6M | 47.84M | 29.59M | n/a | n/a |
| Other Investing Acitivies | 259K | 73.23M | -627K | -1.26M | -1.46M | -1.11M | 732K | 88K | 60K | 234K | -1.22M | -3.38M | -2.3M | -3.56M | -127K | 18K | 4K | 83K | n/a | n/a | 71K | 24.96M | n/a | n/a | n/a |
| Investing Cash Flow | -4.3M | 72.78M | -80.04M | 47.47M | -23.66M | 24.96M | -19.47M | 24.88M | 44.61M | 62.93M | 72.38M | -39.05M | -62.85M | -53.4M | -30.66M | -26.97M | -7.79M | 3.95M | -2.15M | -25.8M | -37.31M | 19.49M | -21.15M | -7.58M | -7.09M |
| Debt Repayment | 19.95M | 4.43M | n/a | 9.97M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -800K | -1.14M | -1.45M | 1.62M | -577K | 43K | 100K | -1.39M | -2.21M | -1.71M | -1.3M | 1.06M | 5.28M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -1.58M | 2.12M | 62.67M | 2.6M | 11.37M | 4.73M | 3.51M | 1.6M | 1.76M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 418K | n/a | n/a | n/a | n/a |
| Financial Cash Flow | 18.37M | 6.55M | 62.67M | 12.57M | 11.37M | 71.89M | 117.69M | 25.18M | 7.05M | 1.17M | 1.05M | 139.09M | 141.98M | 820K | 102.16M | 131.99M | 56.78M | 2.84M | 103.61M | 64.83M | 52.83M | 30.08M | -411K | 62.36M | 11.26M |
| Net Cash Flow | 8.33M | 5.57M | -11.48M | 7.85M | -53.8M | 38.03M | 20.66M | -25.82M | 28.25M | -5.65M | -12.63M | 14.85M | 9.76M | -5.84M | -31.29M | 1.5M | -3.22M | -29.05M | 66.28M | 874K | -16.91M | 15.05M | -37.54M | 43.19M | -3.66M |
| Free Cash Flow | -20.74M | -74.21M | 5.25M | -53.45M | -42.97M | -59.93M | -77.72M | -76.69M | -23.96M | -70.17M | -87.28M | -88.57M | -71.68M | 43.18M | -102.92M | -106.03M | -53.14M | -36.75M | -36.96M | -39.7M | -33.68M | -36.16M | -19.21M | -15.21M | -14.92M |